Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA.
University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, CO, USA.
BMJ. 2023 Dec 13;383:e073995. doi: 10.1136/bmj-2022-073995.
Pancreatic cancer remains among the malignancies with the worst outcomes. Survival has been improving, but at a slower rate than other cancers. Multimodal treatment, including chemotherapy, surgical resection, and radiotherapy, has been under investigation for many years. Because of the anatomical characteristics of the pancreas, more emphasis on treatment selection has been placed on local extension into major vessels. Recently, the development of more effective treatment regimens has opened up new treatment strategies, but urgent research questions have also become apparent. This review outlines the current management of pancreatic cancer, and the recent advances in its treatment. The review discusses future treatment pathways aimed at integrating novel findings of translational and clinical research.
胰腺癌仍然是预后最差的恶性肿瘤之一。尽管生存情况有所改善,但速度比其他癌症慢。多年来,包括化疗、手术切除和放疗在内的多模态治疗一直受到研究。由于胰腺的解剖学特征,人们更加关注局部向大血管延伸的治疗选择。最近,更有效的治疗方案的发展为新的治疗策略开辟了道路,但也出现了一些迫切需要研究的问题。本文概述了胰腺癌的当前治疗方法,以及治疗方面的最新进展。还讨论了未来的治疗途径,旨在整合转化和临床研究的新发现。